DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0020500 | Hyperoxaluria | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C2239176 | Liver carcinoma | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C3888018 | Congenital Hyperinsulinism | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0008370 | Cholestasis | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0006826 | Malignant Neoplasms | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0020501 | Primary Hyperoxaluria | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0025521 | Inborn Errors of Metabolism | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | HAO2 | 51179 | hydroxyacid oxidase 2 | Q9NYQ3 |
C4518337 | Spinocerebellar ataxia type 38 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0007102 | Malignant tumor of colon | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0036341 | Schizophrenia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0007758 | Cerebellar Ataxia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0011849 | Diabetes Mellitus | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C2675481 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0376358 | Malignant neoplasm of prostate | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0087012 | Ataxia, Spinocerebellar | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C1837315 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 1 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0017601 | Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0022658 | Kidney Diseases | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0152136 | Low Tension Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0027051 | Myocardial Infarction | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0009402 | Colorectal Carcinoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0027651 | Neoplasms | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0020456 | Hyperglycemia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024